---
title: "Synexus Clinical Research Midco No 3 Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/b27e2440-d0fc-4871-be65-c8a01684fefb
json: https://whiteintel.dev/api/public/dossier/b27e2440-d0fc-4871-be65-c8a01684fefb
identifier: gb-coh:07293267
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Synexus Clinical Research Midco No 3 Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:07293267`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/b27e2440-d0fc-4871-be65-c8a01684fefb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/b27e2440-d0fc-4871-be65-c8a01684fefb  

## Ownership & control

### Owners / controllers

- **Synexus Clinical Research Midco No 2 Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/16adb898-309c-460e-87e5-84fbd2fc8730

### UBO chain (walk to the ultimate owner)

A **19-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `07293267`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2010-06-23
- **Registered office:** 12b Granta Park, Great Abington, Cambridge, CB21 6GQ, England
- **SIC:** 74909

### Officers

- HARRIS, Richard Stuart — director · British · appointed 2021-12-29
- JAMES, Julia Mary — director · British · appointed 2016-05-31
- TRAVERS SMITH SECRETARIES LIMITED — corporate secretary · appointed 2010-06-23 · resigned 2010-08-11
- BERTHOUX, Christophe — director · French · appointed 2010-11-23 · resigned 2016-05-31
- BRACKEN, Ruth — director · British · appointed 2010-06-23 · resigned 2010-08-11
- CHAMBERS, Paul Michael — director · British · appointed 2011-09-23 · resigned 2016-05-31
- FORT, Michael John — director · British · appointed 2010-11-23 · resigned 2011-04-08
- HAND, Jeremy, Mr. — director · British · appointed 2010-08-11 · resigned 2010-11-23
- HARLAND, David William Romanis — director · British · appointed 2010-08-11 · resigned 2010-11-23
- HARTMAN, Brainard Judd — director · American · appointed 2016-05-31 · resigned 2021-12-08
- MCCLUSKEY, Paul — director · British · appointed 2010-11-23 · resigned 2011-06-30
- NEILD, Christopher David — director · British · appointed 2016-05-31 · resigned 2020-03-13
- TRAVERS SMITH LIMITED — corporate director · appointed 2010-06-23 · resigned 2010-08-11
- TRAVERS SMITH SECRETARIES LIMITED — corporate director · appointed 2010-06-23 · resigned 2010-08-11

### Beneficial owners (Persons with Significant Control)

- [Synexus Clinical Research Midco No 2 Limited](https://whiteintel.dev/entity/16adb898-309c-460e-87e5-84fbd2fc8730) — 75–100% shares · corporate PSC · England — since 2016-04-06

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Synexus Clinical Research Midco No 3 Limited**. Human view: https://whiteintel.dev/entity/b27e2440-d0fc-4871-be65-c8a01684fefb · Structured JSON: https://whiteintel.dev/api/public/dossier/b27e2440-d0fc-4871-be65-c8a01684fefb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._